Ionis Pharmaceuticals
IONS
IONS
270 hedge funds and large institutions have $4.46B invested in Ionis Pharmaceuticals in 2017 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 87 increasing their positions, 93 reducing their positions, and 58 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
14% less capital invested
Capital invested by funds: $5.2B → $4.46B (-$738M)
29% less funds holding in top 10
Funds holding in top 10: 7 → 5 (-2)
53% less first-time investments, than exits
New positions opened: 27 | Existing positions closed: 58
Holders
270
Holding in Top 10
5
Calls
$73.3M
Puts
$62.6M
Top Buyers
| 1 | +$263M | |
| 2 | +$135M | |
| 3 | +$22.8M | |
| 4 |
BB
BB Biotech
Schaffhausen,
Switzerland
|
+$22M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$15.5M |
Top Sellers
| 1 | -$24.1M | |
| 2 | -$23.8M | |
| 3 | -$22.5M | |
| 4 |
Axa
Paris,
France
|
-$15.3M |
| 5 |
Bank of Nova Scotia
Toronto,
Ontario, Canada
|
-$14.3M |